CSE - Canadian Securities Exchange

HydroGraph Clean Power’s (CSE:HG) unique approach to ultra-pure production could spur the wider adoption needed for graphene to truly take off.

In The Global Issue of Canadian Securities Exchange Magazine, we spoke with CEO Kjirstin Breure about the company’s patented detonation synthesis process, commercialization, stages of testing, as well as plans for scaling production.

Read now: https://go.thecse.com/CSE-Magazine-Blog-HydroGraph

Phase II trials for an epilepsy drug and peer success are fuelling a standout year for Bright Minds Biosciences (CSE:DRUG).

In The Global Issue of Canadian Securities Exchange Magazine, we sat down with Chief Executive Officer Ian McDonald to discuss the company's focus on its serotonin-targeting drug, how its lead compound, BMB-101, avoids negative side effects, and its plans to take the molecule to the edge of commercialization.

Read now: https://go.thecse.com/CSE-Magazine-Blog-Bright-Minds-Biosciences